Biogen reanalyzes studies, presses ahead on Alzheimer’s drug
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer’s disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement was a surprise because the drug company earlier this year stopped two studies of the drug when […]
Biogen reanalyzes studies, presses ahead on Alzheimer’s drug Read More »